MDEChem, Inc. (MDKM) Research

MDEChem, Inc., established in 1996 and operating from Floresville, Texas, is a developer and supplier of pharmaceutical and chemical products. Among its key offerings is MaxHeal, an anti-inflammatory, non-steroidal skin restoration gel designed to deliver rapid comfort for minor cuts, scrapes, superficial burns (including sunburn), and abrasions. This gel also effectively soothes the itch and irritation caused by insect bites from pests such as chiggers, mosquitoes, sand fleas, black flies, and other biting insects. Furthermore, the company provides SANDKLENE 950, a non-toxic chemical solution crucial for the efficient recovery of oil from tar and oil sands.

Market snapshot

Symbol
MDKM
Price
$0.00
Day change
-100.00%
Market cap
$630.0
52-week range
3.0E-5-0.001
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • ACI Global Corporation (ACGJ)
  • Allena Pharmaceuticals, Inc. (ALNAQ)
  • Arch Therapeutics, Inc. (ARTH)
  • Beleave Inc. (BLEVF)
  • IMV Inc. (IMVIQ)
  • Micron Solutions, Inc. (MICRD)
  • Molecular Templates, Inc. (MTEM)
  • Mountain High Acquisitions Corp. (MYHI)

Open MDEChem, Inc. (MDKM) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.